专题：Hepatitis B Virus Studies

This cluster of papers focuses on the epidemiology, clinical management, antiviral therapy, and global burden of hepatitis B virus (HBV) infection. It covers topics such as chronic hepatitis B, hepatocellular carcinoma, viral hepatitis, antiviral therapy, vaccine prevention, and the immune response to HBV infection.
最新文献
Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation

article Full Text OpenAlex

Prevalence characteristics of cervical human papillomavirus infection in Chengdu and Aba District, Sichuan Province, China

article Full Text OpenAlex

The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer

article Full Text OpenAlex

Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study

article Full Text OpenAlex

Identifying liver cirrhosis in patients with chronic hepatitis B: an interpretable machine learning algorithm based on LSM

article Full Text OpenAlex

Analysis of a novel mathematical model for HBV and HIV incorporating vertical transmission and intervention measures

article Full Text OpenAlex

Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy

article Full Text OpenAlex

The increase of long noncoding RNA Fendrr in hepatocytes contributes to liver fibrosis by promoting IL-6 production

article Full Text OpenAlex

Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy

article Full Text OpenAlex

Inequities in human papillomavirus vaccination among children aged 9–14 years old under constrained vaccine supply in China

article Full Text OpenAlex

近5年高被引文献
Global burden of primary liver cancer in 2020 and predictions to 2040

article Full Text OpenAlex 1648 FWCI370.96891859

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

article Full Text OpenAlex 1115 FWCI178.65158344

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

article Full Text OpenAlex 994 FWCI130.72374336

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

article Full Text OpenAlex 851 FWCI60.0509786

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 695 FWCI155.74859619

Global epidemiology of cirrhosis — aetiology, trends and predictions

review Full Text OpenAlex 604 FWCI215.36318183

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

review Full Text OpenAlex 593 FWCI111.53203753

Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation

review Full Text OpenAlex 569 FWCI84.00544676

Global Epidemiology of Chronic Liver Disease

review Full Text OpenAlex 518 FWCI78.40508364

Global, regional and national burden of primary liver cancer by subtype

article Full Text OpenAlex 447 FWCI67.88838088